Niva Bupa Q1: PAT ₹138 Cr, near-doubles YoY on Ind AS basis; combined ratio to 93.6%
PAT +92.9% YoY · revenue +28.6% · margins expanding
₹2,273.72 Cr
+28.6% YoY
₹137.8 Cr
+92.9% YoY
5.57%
+12.6pp YoY
₹0.75
Niva Bupa reported its first quarter under Ind AS 117 (adopted 1-Apr-2026), and on the filing's own restated comparatives the print is strong: standalone PAT of ₹137.80 Cr rose ~93% from ₹71.44 Cr a year ago, while insurance revenue grew 28.6% YoY to ₹2,273.72 Cr and gross written premium climbed 31.7% YoY to ₹2,149.96 Cr. A word on the base: our records carry the year-ago quarter as a ₹91.44 Cr loss under the old GAAP, so on a headline basis this reads like a turnaround — but the company has restated Q1FY26 to a ₹71.44 Cr Ind AS profit, and the honest comparison is growth-on-growth, not loss-to-profit. There are no exceptional items on either side, so reported and underlying growth are the same.
Q1 FY-2027 vs prior quarters
The quality of the quarter is in the ratios. The combined operating ratio improved to 93.55% from 98.50% a year ago, driven by a lower claims ratio (63.01% vs 66.83%) and a leaner expense ratio (30.54% vs 31.67%) — i.e. both the loss and cost sides moved the right way, lifting net insurance margin to 4.44% from 0.43%. Return on equity rose to 3.71% from 2.11%. Sequentially, though, the print softened: PAT fell 13.5% from Q4FY26's ₹159.36 Cr, margin slipped from 5.26%, and the expense ratio ticked up from 29.66% — a normal give-back after a seasonally heavy March quarter, not a trend break.
The stock went into the print at ₹85.5, up 0.4% over the past month of trading.
For context: revenue is at a 5-quarter high.
Management projects a long-term combined operating ratio of approximately 99% by FY2029, driven by significant operating leverage and improved expense ratios, leading to a mid-to-high teens ROE. Growth is expected to be sustained through the continued expansion of their multi-channel distribution, a focus on the 'Bhara
— This quarter: beat
Against management's own framing, the quarter tracks well ahead of plan: on the last concall the board guided to a ~99% long-term combined ratio by FY2029 and mid-to-high-teens ROE off operating leverage and expense efficiency, and at 93.55% the combined ratio is already inside that target with the claims ratio broadly stable, exactly as guided. On the Street, brokerages have modelled ~15-20% PAT growth for FY27 (supporting a ₹96 target) with no specific Q1 consensus on record; the ~93% restated YoY jump flatters against that full-year bar and is not a clean read given the Ind AS transition, so we mark the print vs Street as unknown rather than a beat.
W1
Solvency trajectory after the ₹500 Cr NCD raise — held at 2.25x vs 2.86x a year ago against 30%+ GWP growth
W2
Expense ratio: 30.54% this quarter vs the glide toward management's cost-efficiency-led COR target; watch for the ~99% long-term COR path (already at 93.55%)
W3
Claims ratio stability at ~63% (mgmt guided 'largely stable') as the book scales into H2
Clean digital PDF, standalone only (no consolidated). Insurer format under Ind AS 117; statement in ₹ Lakhs. FIRST quarter reported under Ind AS (adopted 1-Apr-2026) — comparatives restated: year-ago Q1FY26 PAT is ₹71.44 Cr under Ind AS vs ₹-91.44 Cr loss under old GAAP (our DB base is old-GAAP; all YoY/QoQ here use the filing's Ind AS-restated comparatives). No exceptional items either period. revenueFromOperations=Insurance Revenue; otherIncome=investment income ₹197.54 Cr + other income ₹0.49 Cr; totalIncome=Total Segment Income; totalExpenses derived (totalIncome−PBT). Tax = deferred tax only (current tax nil). Emphasis-of-matter on pending IRDAI EOM forbearance for FY24-25 (no P&L impact quantifiable).
Informational and educational content only. Not investment advice.